FDA panel votes to modify Avandia restrictions

WASHINGTON (Reuters) - U.S. health advisers voted on Thursday to recommend modifying market restrictions on GlaxoSmithKline's diabetes drug Avandia, the one-time blockbuster at the center of one of the biggest drug controversies in recent years.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news